Phenotyping of N-acetyltransferase type 2 by caffeine from uncontrolled dietary exposure

被引：0
|
作者：
Alexander Jetter
Martina Kinzig-Schippers
Michael Illauer
Robert Hermann
Katharina Erb
Jürgen Borlak
Helga Wolf
Gillian Smith
Ingolf Cascorbi
Fritz Sörgel
Uwe Fuhr
机构：
[1] University of Cologne,Department of Pharmacology, Clinical Pharmacology
[2] Institute for Biomedical and Pharmaceutical Research,Biomedical Research Centre
[3] ALTANA Pharma Deutschland GmbH,Institute of Pharmacology
[4] Clinphase–clinical pharmacology services,undefined
[5] ITEM Fraunhofer-Institut,undefined
[6] Ninewells Hospital and Medical School,undefined
[7] University of Greifswald,undefined
来源：
European Journal of Clinical Pharmacology | 2004年 / 60卷
关键词：
Caffeine; Arylamine; -acetyltransferase 2; Phenotype;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：17 / 21
页数：4
相关论文
共 50 条
  • [31] Targeted inhibition of N-acetyltransferase, type 2 (NAT2) in healthy volunteers.
    Cantilena, LR
    Katki, AG
    Klecker, RW
    Collins, JM
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P58 - P58
  • [32] Generation and analysis of mice with a targeted disruption of the arylamine N-acetyltransferase type 2 gene
    V A Cornish
    K Pinter
    S Boukouvala
    N Johnson
    C Labrousse
    M Payton
    H Priddle
    A J H Smith
    E Sim
    The Pharmacogenomics Journal, 2003, 3 : 169 - 177
  • [33] N-Acetyltransferase 2 Polymorphisms and Susceptibility to Infant Leukemia with Maternal Exposure to Dipyrone during Pregnancy
    Zanrosso, Crisiane Wais
    Emerenciano, Mariana
    de Aguiar Goncalves, Bruno Alves
    Faro, Alessandra
    Koifman, Sergio
    Pombo-de-Oliveira, Maria S.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010, 19 (12) : 3037 - 3043
  • [34] Expression and purification of human arylamine N-acetyltransferase 2
    Baker, Inesha
    Hurlbert, Jason
    Parker, Chasta L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 771 - 771
  • [35] Reconstruction of N-acetyltransferase 2 haplotypes using PHASE
    Klaus Golka
    Meinolf Blaszkewicz
    Mirabutaleb Samimi
    Hermann M. Bolt
    Silvia Selinski
    Archives of Toxicology, 2008, 82 : 265 - 270
  • [36] PURIFICATION AND PROPERTIES OF N-ACETYLTRANSFERASE FROM MAMMALIAN LIVER
    WEBER, WW
    COHEN, SN
    STEINBERG, MS
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1968, 151 (A2) : 734 - +
  • [37] POLYAMINE N-ACETYLTRANSFERASE FROM FASCIOLA-HEPATICA
    AISIEN, SO
    WALTER, RD
    MOLECULAR AND BIOCHEMICAL PARASITOLOGY, 1992, 51 (01) : 65 - 72
  • [38] N-acetyltransferase 2 polymorphism in patients with Diabetes Mellitus
    Yalin, Serap
    Hatungil, Rezan
    Tamer, Lulufer
    Ates, Nurcan Aras
    Dogruer, Nil
    Yildirim, Hatice
    Karakas, Sevim
    Atik, Ugur
    CELL BIOCHEMISTRY AND FUNCTION, 2007, 25 (04) : 407 - 411
  • [39] N-acetyltransferase 2, exposure to aromatic and heterocyclic amines, and receptor-defined breast cancer
    Rabstein, Sylvia
    Bruening, Thomas
    Harth, Volker
    Fischer, Hans-Peter
    Haas, Susanne
    Weiss, Tobias
    Spickenheuer, Anne
    Pierl, Christiane
    Justenhoven, Christina
    Illig, Thomas
    Vollmert, Caren
    Baisch, Christian
    Ko, Yon-Dschun
    Hamann, Ute
    Brauch, Hiltrud
    Pesch, Beate
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2010, 19 (02) : 100 - 109
  • [40] Neuroendocrine expression of mouse arylamine N-acetyltransferase 2
    Wakefield, Larissa
    Kawamura, Akane
    Long, Hilary
    Sim, Edith
    GENETICAL RESEARCH, 2006, 88 (01) : 74 - 74
12345